APA Citatie

Desai, J., Gan, H., Barrow, C., Jameson, M., Atkinson, V., Haydon, A., . . . Solomon, B. (2020). Phase I, Open-Label, Dose-Escalation/Dose-Expansion Study of Lifirafenib (BGB-283), an RAF Family Kinase Inhibitor, in Patients With Solid Tumors. J Clin Oncol.

Chicago Style citaat

Desai, Jayesh, et al. "Phase I, Open-Label, Dose-Escalation/Dose-Expansion Study of Lifirafenib (BGB-283), an RAF Family Kinase Inhibitor, in Patients With Solid Tumors." J Clin Oncol 2020.

MLA citatie

Desai, Jayesh, et al. "Phase I, Open-Label, Dose-Escalation/Dose-Expansion Study of Lifirafenib (BGB-283), an RAF Family Kinase Inhibitor, in Patients With Solid Tumors." J Clin Oncol 2020.